BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 5, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Novel duocarmycin derivative suitable for use in anticancer immunoconjugates
Sep. 15, 2000
NCI sponsors additional phase II studies of Prostvac VF vaccine
Sep. 13, 2000
StressGen commences phase II trial of HspE7 for treatment of cervical cancer
Sep. 12, 2000
Maxamine granted priority FDA review for melanoma
Sep. 8, 2000
Herceptin approved in E.U. for treatment of HER2-positive metastatic breast cancer
Aug. 30, 2000
Cancer vaccine shows potential for decreasing risk of relapse and death
Aug. 30, 2000
LifeTime Pharmaceuticals announces U.S. phase I/II trials of Beta LT for cancer
Aug. 29, 2000
Cel-Sci to commence phase II Multikine study in Czech Republic
Aug. 24, 2000
Ilex and Millennium respond to FDA letter on Campath
Aug. 24, 2000
Bioniche reports preclinical findings for MCC in prostate cancer
Aug. 21, 2000
Previous
1
2
…
938
939
940
941
942
943
944
945
946
…
1003
1004
Next
RSS